{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:56:34Z","timestamp":1773323794348,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,11]]},"DOI":"10.7759\/cureus.105068","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:32:27Z","timestamp":1773268347000},"source":"Crossref","is-referenced-by-count":0,"title":["The Role of 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography\/Computed Tomography (PET\/CT) Values in the Detection of Bladder Carcinoma"],"prefix":"10.7759","author":[{"given":"Rika","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshizako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shota","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Katsube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Tsuchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2020.03.31","article-title":"Role of PET\/CT in muscle-invasive bladder cancer","volume":"9","author":"Kim SK","year":"2020","unstructured":"Kim SK. Role of PET\/CT in muscle-invasive bladder cancer. Transl Androl Urol. 2020, 9:2908-19. 10.21037\/tau.2020.03.31","journal-title":"Transl Androl Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000798","article-title":"18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in muscle-invasive bladder cancer","volume":"30","author":"Einerhand SM","year":"2020","unstructured":"Einerhand SM, van Gennep EJ, Mertens LS, Hendricksen K, Donswijk ML, van der Poel HG, van Rhijn BW. 18F-fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography in muscle-invasive bladder cancer. Curr Opin Urol. 2020, 30:654-64. 10.1097\/MOU.0000000000000798","journal-title":"Curr Opin Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10090703","article-title":"The role of imaging in bladder cancer diagnosis and staging","volume":"10","author":"Galgano SJ","year":"2020","unstructured":"Galgano SJ, Porter KK, Burgan C, Rais-Bahrami S. The role of imaging in bladder cancer diagnosis and staging. Diagnostics (Basel). 2020, 10:16-8. 10.3390\/diagnostics10090703","journal-title":"Diagnostics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.75771","article-title":"18F-FDG PET\/CT imaging in oncology","volume":"31","author":"Almuhaideb A","year":"2011","unstructured":"Almuhaideb A, Papathanasiou N, Bomanji J. 18F-FDG PET\/CT imaging in oncology. Ann Saudi Med. 2011, 31:3-13. 10.4103\/0256-4947.75771","journal-title":"Ann Saudi Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12608","article-title":"Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer","volume":"114","author":"Goodfellow H","year":"2014","unstructured":"Goodfellow H, Viney Z, Hughes P, et al.. Role of fluorodeoxyglucose positron emission tomography (FDG PET)-computed tomography (CT) in the staging of bladder cancer. BJU Int. 2014, 114:389-95. 10.1111\/bju.12608","journal-title":"BJU Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.05.014","article-title":"FDG-PET\/CT for the preoperative lymph node staging of invasive bladder cancer","volume":"57","author":"Swinnen G","year":"2010","unstructured":"Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P. FDG-PET\/CT for the preoperative lymph node staging of invasive bladder cancer. Eur Urol. 2010, 57:641-7. 10.1016\/j.eururo.2009.05.014","journal-title":"Eur Urol"},{"key":"ref7","article-title":"TNM Classification of Malignant Tumours","year":"2017","unstructured":"TNM Classification of Malignant Tumours. Brierley JD, Gospodarowicz MK, Wittekind C (ed). Wiley-Blackwell, Hoboken, NJ; 2017."},{"key":"ref8","article-title":"WHO Classification of Tumours Editorial Board. Urinary and male genital tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board. Urinary and Male Genital Tumours. IARC Press, Lyon, France; 2022. https:\/\/publications.iarc.who.int\/Book-And-Report-Series\/Who-Classification-Of-Tumours\/Urinary-And-Male-Genital-Tumou...."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2016.10.005","article-title":"Computed diffusion-weighted imaging using 1.5-T magnetic resonance imaging for prostate cancer diagnosis","volume":"41","author":"Yoshida R","year":"2017","unstructured":"Yoshida R, Yoshizako T, Katsube T, Tamaki Y, Ishikawa N, Kitagaki H. Computed diffusion-weighted imaging using 1.5-T magnetic resonance imaging for prostate cancer diagnosis. Clin Imaging. 2017, 41:78-82. 10.1016\/j.clinimag.2016.10.005","journal-title":"Clin Imaging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s40644-016-0091-3","article-title":"How we read oncologic FDG PET\/CT","volume":"16","author":"Hofman MS","year":"2016","unstructured":"Hofman MS, Hicks RJ. How we read oncologic FDG PET\/CT. Cancer Imaging. 2016, 16:35. 10.1186\/s40644-016-0091-3","journal-title":"Cancer Imaging"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-016-1772-z","article-title":"The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis","volume":"34","author":"Soubra A","year":"2016","unstructured":"Soubra A, Hayward D, Dahm P, Goldfarb R, Froehlich J, Jha G, Konety BR. The diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography and computed tomography in staging bladder cancer: a single-institution study and a systematic review with meta-analysis. World J Urol. 2016, 34:1229-37. 10.1007\/s00345-016-1772-z","journal-title":"World J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3109\/00365599.2010.544672","article-title":"Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography\/computed axial tomography and magnetic resonance imaging: correlation with histopathology","volume":"45","author":"Jensen TK","year":"2011","unstructured":"Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography\/computed axial tomography and magnetic resonance imaging: correlation with histopathology. Scand J Urol Nephrol. 2011, 45:122-8. 10.3109\/00365599.2010.544672","journal-title":"Scand J Urol Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/1450-1147.138572","article-title":"Role of fluorodeoxyglucose positron emission tomography\/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography","volume":"13","author":"Chakraborty D","year":"2014","unstructured":"Chakraborty D, Mittal BR, Kashyap R, et al.. Role of fluorodeoxyglucose positron emission tomography\/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography. World J Nucl Med. 2014, 13:34-9. 10.4103\/1450-1147.138572","journal-title":"World J Nucl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03020-1","article-title":"Diagnostic efficacy of [(18)F]FDG PET\/CT and [(18)F]FDG PET\/MRI in preoperative staging of locoregional urinary bladder cancer: a systematic review and meta-analysis","volume":"16","author":"Abdlkadir AS","year":"2025","unstructured":"Abdlkadir AS, Al-Adhami D, Allouzi S, et al.. Diagnostic efficacy of [(18)F]FDG PET\/CT and [(18)F]FDG PET\/MRI in preoperative staging of locoregional urinary bladder cancer: a systematic review and meta-analysis. Discov Oncol. 2025, 16:1241. 10.1007\/s12672-025-03020-1","journal-title":"Discov Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1055\/s-0045-1812491","article-title":"Diagnostic performance of [(18) F]FDG PET\/MRI and [(18) F]FDG PET\/CT in the detection of lymph node metastases in colorectal cancer: a meta-analysis","volume":"24","author":"Shen D","year":"2025","unstructured":"Shen D, Chen L, Su P, Chen P, Zeng W, Chen S, Shen J. Diagnostic performance of [(18) F]FDG PET\/MRI and [(18) F]FDG PET\/CT in the detection of lymph node metastases in colorectal cancer: a meta-analysis. World J Nucl Med. 2025, 24:279-92. 10.1055\/s-0045-1812491","journal-title":"World J Nucl Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.12.003","article-title":"Future role of [18F]-FDG PET\/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy?","volume":"39","author":"Girard A","year":"2021","unstructured":"Girard A, Vila Reyes H, Dercle L, Rouanne M. Future role of [18F]-FDG PET\/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy?. Urol Oncol. 2021, 39:139-41. 10.1016\/j.urolonc.2020.12.003","journal-title":"Urol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/463509-the-role-of-18f-fluorodeoxyglucose-18f-fdg-positron-emission-tomographycomputed-tomography-petct-values-in-the-detection-of-bladder-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:32:28Z","timestamp":1773268348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/463509-the-role-of-18f-fluorodeoxyglucose-18f-fdg-positron-emission-tomographycomputed-tomography-petct-values-in-the-detection-of-bladder-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.105068","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,11]]}}}